Through the CDC’s National SARS-CoV-2 Strain Surveillance Program, MCIDT’s Adam Lauring helped antigenically characterize Delta, Mu, and Omicron COVID-19 subvariants, developing a framework applicable to emerging variants to assess vaccine/antigen efficacy
Key Terms: COVID-19, Strains, Omicron